Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity
eLife · 2025
DOI: 10.7554/elife.99281 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Jingbo Kan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, United States. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Ribosomal Proteins, Anti-Bacterial Agents, Bacterial Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, National Institute for Health Care Management Foundation.
Abstract (Originalsprache)
Gonorrhea, which is caused by Neisseria gonorrhoeae , is the second most reported sexually transmitted infection worldwide. The increasing appearance of isolates that are resistant to approved therapeutics raises the concern that gonorrhea may become untreatable. Here, we serendipitously identified oxydifficidin as a potent N. gonorrhoeae antibiotic through the observation of a Bacillus amyloliquefaciens contaminant in a lawn of N. gonorrhoeae . Oxydifficidin is active against both wild-type and multidrug-resistant N. gonorrhoeae . Its potent activity results from a combination of DedA-assisted uptake into the cytoplasm and the presence of an oxydifficidin-sensitive ribosomal protein L7/L12 (RplL). Our data indicate that oxydifficidin binds to the ribosome at a site that is distinct from other antibiotics and that L7/L12 is uniquely associated with its mode of action. This study opens a potential new avenue for addressing antibiotic resistant gonorrhea and underscores the possibility of identifying overlooked natural products from cultured bacteria, particularly those with activity against previously understudied pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genetically Encoded Small Molecules, The Rockefeller University, New York, United States.
- Graduate Center, City University of New York, New York City, United States.
- Brooklyn College, City University of New York, New York, United States.
- Laboratoire Jean Perrin, UMR 8237 Sorbonne Université/CNRS, Paris, France.
ORCID-Profile: Jingbo Kan, Adrian Morales-Amador, Yozen Hernandez, Nicolas Biais, Sean F Brady
Förderung
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institute for Health Care Management Foundation
- iBio Initiative
Zitieren
APA
Kan, J., Morales-Amador, A., Hernandez, Y., Ternei, M. A., Lemetre, C., Maclntyre, L. W., Biais, N., & Brady, S. F. (2025). Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity. eLife. https://doi.org/10.7554/elife.99281
Vancouver
Kan J, Morales-Amador A, Hernandez Y, Ternei MA, Lemetre C, Maclntyre LW, et al. Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity. eLife. 2025. doi:10.7554/elife.99281
BibTeX
@article{Kan2025,
author = {Kan, Jingbo and Morales-Amador, Adrian and Hernandez, Yozen and Ternei, Melinda A and Lemetre, Christophe and Maclntyre, Logan W and Biais, Nicolas and Brady, Sean F},
title = {Oxydifficidin, a potent Neisseria gonorrhoeae antibiotic due to DedA-assisted uptake and ribosomal protein RplL sensitivity},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.99281}
}
EUVIMED